Biology › Section E · Cell communication and the cell cycle › Topic E.1
Signaling molecules and receptors
Cells have no mouths, so they talk in chemistry: one cell releases a small molecule, and only cells carrying the matching receptor respond. Here you will meet the four ways signals travel - to nearby cells, distant cells, the cell itself, and straight through junctions between neighbors - and the two kinds of receptors, internal and cell-surface, that turn a molecular handshake into action.
Cells talk in chemistry
Communication between cells is intercellular signaling; communication within a cell is intracellular signaling. A signaling cell releases a ligand - a small, usually volatile or soluble molecule that binds another specific molecule, delivering a signal. Cells affected by chemical signals are target cells, and the proteins ligands bind are receptors. The fit is specific: a given ligand typically has one receptor that binds it, though some receptors recognize several ligands. Nearly every pathway runs three stages: reception (ligand binds receptor), signal transduction (the message is relayed and amplified inside), and cellular response.
Paracrine signaling: talk to your neighbors
Paracrine signals act locally, diffusing through the extracellular matrix between cells that are close together, and they usually trigger quick, short-lived responses. To keep the message local, enzymes degrade the ligand rapidly or neighboring cells mop it up. The classic example is the synapse between nerve cells: when an electrical impulse reaches the end of an axon, the presynaptic cell releases neurotransmitters into the tiny chemical synapse; they diffuse across, and binding on the postsynaptic cell launches the next impulse. Quick degradation or reabsorption lets the recipient fire again immediately - the speed you need to snatch your hand off a hot stove.
Endocrine signaling: talk to the whole body
Endocrine signals travel from distant cells via the bloodstream. Endocrine cells, often clustered in glands like the thyroid, hypothalamus, and pituitary, release hormones - ligands produced in one part of the body that act on other regions some distance away. Blood is a slow route, so responses start slower than paracrine ones, but their effects last longer. Transport also dilutes the signal: hormones arrive at their targets in low concentrations, unlike paracrine ligands, which can be locally concentrated.
Autocrine signaling and direct contact
Autocrine signals are released by cells that also bind them - the signaling cell is its own target. This self-addressed mail is common in early development, helping identical cells differentiate together, and it regulates pain sensation and inflammation. A virus-infected cell can even signal itself to undergo programmed cell death, taking the virus down with it. For tighter coupling, animal cells connect through gap junctions and plant cells through plasmodesmata: fluid-filled channels linking neighbors' cytoplasm. Small intracellular mediators like calcium ions diffuse through, but large proteins and DNA cannot; the channels keep cells independent while letting a group coordinate a response only one of them received.
Internal receptors: straight to the genes
Internal receptors - also called intracellular or cytoplasmic receptors - sit in the cytoplasm and respond to hydrophobic ligands, which slip across the plasma membrane unaided. Binding triggers a shape change that exposes a DNA-binding site; the ligand-receptor complex moves into the nucleus, binds regulatory regions of chromosomal DNA, and promotes the initiation of transcription - copying DNA's information into mRNA. Many internal receptors are transcription factors, so they influence gene expression directly.
Cell-surface receptors: the gatekeepers
Cell-surface receptors, also called transmembrane receptors, are membrane-spanning integral proteins that bind external ligands - which never have to enter the cell they affect. They convert an extracellular signal into an intracellular one. Each has three components: an external ligand-binding domain (the extracellular domain), a hydrophobic membrane-spanning region, and an intracellular domain, with sizes varying widely by receptor type. Because these proteins are fundamental to normal cell function, malfunctions are severe: receptor errors contribute to hypertension, asthma, heart disease, and cancer. Cell-surface receptors handle most signaling in multicellular organisms and come in three categories: ion channel-linked, G-protein-linked, and enzyme-linked.
Ion channels and G proteins
Ion channel-linked receptors bind a ligand and open a pore: their membrane-spanning region faces the lipid tails with hydrophobic amino acids and lines the channel with hydrophilic ones, so binding on the outside changes the protein's shape and lets ions such as sodium, calcium, magnesium, and hydrogen flow through. G-protein-linked receptors work by proxy: ligand binding activates a G protein, which swaps its GDP for GTP and splits into alpha and beta-gamma subunits, either of which can trigger the next protein. Hydrolysis of GTP back to GDP ends the signal, the subunits rejoin, and the cycle restarts. Every G-protein-linked receptor has seven transmembrane domains but its own extracellular domain and G-protein-binding site.
Enzyme-linked receptors: the tyrosine kinase
Enzyme-linked receptors carry intracellular domains that are enzymes or bind directly to one, with large domains on both sides of a single alpha-helical membrane span. The best-studied example is the receptor tyrosine kinase, which moves phosphate groups from ATP onto tyrosine residues. Signaling molecules bind two nearby receptors, which bond together - dimerize - and phosphorylate each other's tyrosines. The phosphorylated residues relay the signal to the next cytoplasmic messenger, and a phosphatase stripping the phosphates back off terminates it. The stakes are high: in about 30 percent of human breast cancers, the receptor tyrosine kinase HER2 is permanently active - the drug lapatinib blocks its autophosphorylation.
Worked example: how a virus picks its host
Viruses have no plasma membrane and cannot reproduce alone, so they must invade a host - and they find it through your own receptors. Influenza binds specific cell-surface receptors on cells of the human respiratory tract. Because those receptors differ chemically between species, a virus adapted to humans generally cannot infect chickens, and vice versa. But viral genomes are tiny and copy fast, so errors are frequent - and a random change in a viral surface protein can let it bind a new host's receptors. The change matters only if the variant then contacts a suitable host, which is why farms mixing people, poultry, and pigs are watched closely for emerging viruses.
Worked example: cholera's locked-on switch
Predict what happens when a toxin locks a G protein on. The water-borne bacterium Vibrio cholerae releases choleragen, which enters cells lining the small intestine and modifies the G protein controlling a chloride channel - it cannot hydrolyze its GTP and stays permanently active. The channel stays open, chloride pours out, water follows, and the body loses massive fluid - cholera's potentially fatal dehydration. Apply the mechanism in reverse: a drug stabilizing the GTP-bound form would do the same harm, while one speeding GTP hydrolysis would shut the channel - pathway logic is predictable enough to design cures around.
Common mistakes to avoid
First, calling every signaling molecule a hormone - hormones are specifically endocrine ligands. Second, confusing intercellular with intracellular signaling - between cells versus inside one cell. Third, assuming all receptors sit on the membrane - internal receptors in the cytoplasm serve hydrophobic ligands like steroids. Fourth, forgetting that ligand chemistry dictates the route: small hydrophobic ligands (steroids, thyroid hormone, vitamin D) cross the membrane; water-soluble ligands must bind cell-surface receptors. Fifth, lumping the three surface-receptor categories together - ion channels open pores, G-protein receptors relay through a GTP switch, enzyme-linked receptors phosphorylate. Sixth, forgetting that GTP hydrolysis ends a G-protein signal.
Key takeaways
Cells communicate with ligands - small molecules that bind specific receptors on target cells - through three stages: reception, transduction, and response. Four signaling types are distinguished by distance: paracrine (nearby, fast, short-lived, as at synapses), endocrine (hormones through blood, slow but lasting, arriving diluted), autocrine (a cell signaling itself, as in development, pain, and infected-cell suicide), and direct contact through gap junctions or plasmodesmata, which pass small mediators like calcium but not proteins. Small hydrophobic ligands like steroids diffuse in to bind internal receptors - transcription factors acting directly on DNA; water-soluble ligands bind cell-surface receptors with extracellular, membrane-spanning, and intracellular domains. Those split into ion channel-linked receptors that open pores, G-protein-linked receptors that swap GDP for GTP until hydrolysis turns them off, and enzyme-linked receptor tyrosine kinases that dimerize and phosphorylate. Receptor errors drive diseases from cholera to breast cancer, and viruses exploit host receptors to pick their targets.
Flashcards
Flashcard
A small molecule released by a signaling cell that binds a specific molecule, often delivering a signal
Test your understanding
Question 1 of 5
A ligand travels through the bloodstream from a gland and arrives at its target in low concentration. What type of signaling is this?
Question 2 of 5
Why can a steroid hormone bind an internal receptor while a peptide hormone cannot?
Question 3 of 5
In a G-protein-linked receptor pathway, what event terminates the signal?
Question 4 of 5
A cell infected by a virus releases a signal that binds receptors on its own surface, triggering its own programmed cell death. This is:
Question 5 of 5
Influenza viruses infect humans but not chickens. What determines this specificity?
